Proteomics profiling identifies extracellular vesicles’ cargo associated with tumour cell induced platelet aggregation

Cancer patients have an increased risk of developing venous thromboembolism, with up to 30% dying within a month of their development. Some cancer cells are known to induce platelet aggregation, and this interaction is understood to contribute to thrombosis and haematogenous metastasis.